Skip to content

Observational Study for Prone Position Ventilation and Conventional Respiratory Support in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19)

Observational Study for Prone Position Ventilation and Conventional Respiratory Support in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19)

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030741
Enrollment
Unknown
Registered
2020-03-13
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

transnasal high-flow oxygen therapy:prone position ventilation
noninvasive mechanical ventilation:prone position ventilation
invasive mechanical ventilation:prone position ventilation

Sponsors

Shandong Provincial Chest hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were diagnosed as COVID-19 by nucleic acid test; 2. aged 14 years or more; 3. diagnosis of ARDS according to Berlin definition.

Exclusion criteria

Exclusion criteria: 1. Hemodynamic instability: Cardiac pacemaker inserted in the last 2 days or life-threatening arrhythmias or circulatory disorders (use of large doses of vasoactive drugs); 2. Intracranial pressure >30 mm Hg or cerebral perfusion pressure <60 mmHg; 3. Massive hemoptysis requiring an immediate surgical or interventional radiology procedure; 4. Tracheal surgery or sternotomy during the previous 15 days; 5. Serious facial trauma or facial surgery; 6. Deep venous thrombosis treated for less than 2 days; 7. Anterior chest wall placed closed thoracic drainage device; 8. Open wound of abdominal cavity; 9. Unstable spine; 10. femur or pelvic fractures; 11. Pregnant women; 12. Use of extracorporeal membrane oxygenation (ECMO) before inclusion; 13. Chronic respiratory failure requiring oxygen therapy or non-invasive ventilation(NIV); 14. Previous inclusion in the present study; 15. Opposition from next of kin.

Design outcomes

Primary

MeasureTime frame
PaO2;PaCO2;

Countries

China

Contacts

Public ContactFenglin Liu

Shandong Provincial Chest Hospital

xkyylfl@163.com+86 13953116564

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026